You just read:

Boston Biomedical Announces Orphan Drug Designation by FDA for Investigational WT1 Cancer Peptide Vaccine DSP-7888 in Myelodysplastic Syndrome

News provided by

Boston Biomedical, Inc.

Jul 10, 2017, 08:30 ET